Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vericel Corproation (VCEL)

Vericel Corproation (VCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,662,851
  • Shares Outstanding, K 46,094
  • Annual Sales, $ 124,180 K
  • Annual Income, $ 3,040 K
  • 60-Month Beta 2.16
  • Price/Sales 22.20
  • Price/Cash Flow 488.33
  • Price/Book 19.55
Trade VCEL with:

Options Overview

Details
  • Implied Volatility 68.09%
  • Historical Volatility 83.13%
  • IV Percentile 71%
  • IV Rank 33.45%
  • IV High 125.54% on 06/26/20
  • IV Low 39.22% on 11/17/20
  • Put/Call Vol Ratio 0.01
  • Today's Volume 99
  • Volume Avg (30-Day) 201
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 3,397
  • Open Int (30-Day) 1,234

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.06
  • Number of Estimates 4
  • High Estimate 0.00
  • Low Estimate -0.10
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.98 +29.73%
on 03/17/21
60.49 -5.69%
on 04/08/21
+10.37 (+22.22%)
since 03/12/21
3-Month
37.64 +51.57%
on 01/19/21
60.49 -5.69%
on 04/08/21
+18.53 (+48.10%)
since 01/14/21
52-Week
10.35 +451.21%
on 04/15/20
60.49 -5.69%
on 04/08/21
+45.62 (+399.13%)
since 04/14/20

Most Recent Stories

More News
Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company...

VCEL : 57.06 (+0.81%)
Worldwide Cell Therapy Industry to 2027 - Increasing Prevalence of Chronic Diseases is Driving the Market

, /PRNewswire/ -- The report has been added to offering.

BMY : 63.81 (+0.36%)
MESO : 8.70 (+0.69%)
NVS : 86.75 (+0.16%)
NUVA : 68.57 (+0.12%)
SNN : 39.10 (+0.77%)
VCEL : 57.06 (+0.81%)
Vericel Set to Join S&P SmallCap 600

, /PRNewswire/ -- Vericel Corp. (NASD:VCEL) will replace QEP Resources Inc. (NYSE:QEP) in the S&P SmallCap 600 effective prior to the opening of trading on . S&P 500 constituent Diamondback Energy Inc....

VCEL : 57.06 (+0.81%)
QEP : 4.08 (-4.45%)
FANG : 80.34 (+6.05%)
SPGI : 372.03 (-0.25%)
Regenerative Medicine For Cartilage Global Market Report 2021: COVID-19 Growth And Change

Reportlinker.com announces the release of the report "Regenerative Medicine For Cartilage Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06036660/?utm_source=GNW...

CNMD : 130.45 (-1.09%)
OSIR : 18.99 (unch)
SNN : 39.10 (+0.77%)
SYK : 252.29 (-0.50%)
VCEL : 57.06 (+0.81%)
ZBH : 168.31 (-0.09%)
Vericel Corporation (VCEL) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Vericel Corporation (VCEL) closed at $42.92, marking a -0.26% move from the previous day.

VCEL : 57.06 (+0.81%)
Vericel to Present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company...

VCEL : 57.06 (+0.81%)
Vericel Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Life Sciences Conference

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Joe Mara, Chief Financial Officer, will present the latest company...

VCEL : 57.06 (+0.81%)
Global Blood (GBT) Q4 Earnings Miss, Revenues Beat Estimates

Global Blood (GBT) reports a wider-than-expected loss in the fourth quarter of 2020 while revenues beat estimates.

DVAX : 10.14 (+1.81%)
LXRX : 5.19 (-0.19%)
GBT : 41.47 (+3.21%)
VCEL : 57.06 (+0.81%)
Company News for Feb 25, 2021

Companies In The News Are: VCEL, LNG, HZNP, PRAH

LNG : 73.75 (+1.72%)
HZNP : 91.45 (-0.19%)
PRAH : 155.91 (-0.19%)
VCEL : 57.06 (+0.81%)
ACADIA (ACAD) Beats on Q4 Earnings, Misses on Revenues

ACADIA's (ACAD) loss narrows in the fourth quarter of 2020 while it misses estimates for revenues. Nuplazid drives year-over-year revenues.

DVAX : 10.14 (+1.81%)
LXRX : 5.19 (-0.19%)
ACAD : 21.28 (+3.30%)
VCEL : 57.06 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the...

See More

Key Turning Points

3rd Resistance Point 64.86
2nd Resistance Point 62.63
1st Resistance Point 59.62
Last Price 57.06
1st Support Level 54.37
2nd Support Level 52.14
3rd Support Level 49.13

See More

52-Week High 60.49
Last Price 57.06
Fibonacci 61.8% 41.34
Fibonacci 50% 35.42
Fibonacci 38.2% 29.50
52-Week Low 10.35

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar